Carl Icahn drops opposition to Express Scripts-Cigna merger

Published August 14, 2018 4:04pm ET



Activist investor Carl Icahn has dropped his controversial opposition to the merger of insurer Cigna and pharmacy benefit manager Express Scripts, after previously bashing the $60 billion deal.

Icahn’s investment firm said in a statement late Monday that he was abandoning his attempt to stop the deal, but did not elaborate. Icahn holds a small stake in Cigna.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.